Locke Bio creates scalable consumer healthcare solutions that offer personalized patient healthcare and enables advancements in drug discovery. We believe that personalization is future of healthcare, and with our data-driven approach, we can reduce the costs and risks associated with drug discovery to help save lives, while creating personal touch points between consumers and the drug discovery process.
Locke Bio puts patients first. The ownership and management of direct-to-consumer telemedicine brands in high growth geographies allow us to play a unique role between patient and pharmaceuticals. With online platforms, patients can consult with top physicians and practitioners that prescribe medicines that we dispense and deliver. Our scale allows us to build highly personalized healthcare experiences for our patients.